Profile
Full Name
Immunome, Inc.Ticker Symbol
IMNMExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
October 2, 2020Indexes
Not includedWebsite
http://immunome.comEmployees
118Key Details
Price
$8.40(-1.41%)
Market cap
$730.39M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$9.04M(-35.50% YoY)
Annual EPS
-$5.00(+7.06% YoY)
PE ratio
-
Next earnings date
May 14, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Immunome doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Apr 2, 25 Lake Street
BuyMar 20, 25 Wedbush
OutperformMar 20, 25 Stephens & Co.
OverweightMar 20, 25 Guggenheim
BuyMar 11, 25 LifeSci Capital
OutperformNov 14, 24 Piper Sandler
OverweightNov 8, 24 Stephens & Co.
OverweightOct 25, 24 Wedbush
OutperformAug 13, 24 Wedbush
OutperformAug 13, 24 Piper Sandler
OverweightInstitutional Ownership
- What is the ticker symbol for Immunome?
- Does Immunome pay dividends?
- What sector is Immunome in?
- What industry is Immunome in?
- What country is Immunome based in?
- When did Immunome go public?
- Is Immunome in the S&P 500?
- Is Immunome in the NASDAQ 100?
- Is Immunome in the Dow Jones?
- When was Immunome's last earnings report?
- When does Immunome report earnings?
- Should I buy Immunome stock now?
What is the ticker symbol for Immunome?
The ticker symbol for Immunome is NASDAQ:IMNM
Does Immunome pay dividends?
No, Immunome does not pay dividends
What sector is Immunome in?
Immunome is in the Healthcare sector
What industry is Immunome in?
Immunome is in the Biotechnology industry
What country is Immunome based in?
Immunome is headquartered in United States
When did Immunome go public?
Immunome's initial public offering (IPO) was on October 2, 2020
Is Immunome in the S&P 500?
No, Immunome is not included in the S&P 500 index
Is Immunome in the NASDAQ 100?
No, Immunome is not included in the NASDAQ 100 index
Is Immunome in the Dow Jones?
No, Immunome is not included in the Dow Jones index
When was Immunome's last earnings report?
Immunome's most recent earnings report was on Mar 19, 2025
When does Immunome report earnings?
The next expected earnings date for Immunome is May 14, 2025
Should I buy Immunome stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions